P30.02 Assessing SIADH (Syndrome of Inapproriate Antidiuretic Hormone Secretion) Management and Outcome Among Lung Cancer Patients: The Assert Trial

MLA

M.C. Garassino, et al. “P30.02 Assessing SIADH (Syndrome of Inapproriate Antidiuretic Hormone Secretion) Management and Outcome Among Lung Cancer Patients: The Assert Trial.” Journal of Thoracic Oncology, vol. 16, Mar. 2021, pp. S394–95. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........83f388b80d45ea66bcf399b5ea10cb31&authtype=sso&custid=ns315887.

APA

M.C. Garassino, Erika Rijavec, Stefania Gori, R. Berardi, M. Scartozzi, V. De Marino, V. Montesarchio, Giuseppe Altavilla, G. Tonini, Luigi Cavanna, L. Palermo, Roberta Buosi, Daris Ferrari, Francesco Cognetti, M. Tiseo, Mariangela Torniai, Graziella Pinotti, Alberto Morabito, & Salvatore Palazzo. (2021). P30.02 Assessing SIADH (Syndrome of Inapproriate Antidiuretic Hormone Secretion) Management and Outcome Among Lung Cancer Patients: The Assert Trial. Journal of Thoracic Oncology, 16, S394–S395.

Chicago

M.C. Garassino, Erika Rijavec, Stefania Gori, R. Berardi, M. Scartozzi, V. De Marino, V. Montesarchio, et al. 2021. “P30.02 Assessing SIADH (Syndrome of Inapproriate Antidiuretic Hormone Secretion) Management and Outcome Among Lung Cancer Patients: The Assert Trial.” Journal of Thoracic Oncology 16 (March): S394–95. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........83f388b80d45ea66bcf399b5ea10cb31&authtype=sso&custid=ns315887.